| Company* (Country; Symbol) |
Company | Type/Product Area | Terms/Details (Date) |
|
Diversa Corp. (DVSA) |
Bunge Oils Inc. | Agreement to discover and develop novel enzymes for the production of edible oil products with enhanced nutritional or health benefits | Edible oils include cooking oils, shortenings and margarines; Diversa is responsible for discovering and manufacturing enzymes, and Bunge is responsible for commercialization efforts; Diversa has received an up-front technology access fee and will receive research funding; it also is eligible for milestones and royalties (2/22) |
|
Interleukin Genetics Inc. (AMEX:ILI) |
Access Business Group International LLC (subsidiary of Alticor Inc.) | Research agreement encompassing the development of genetic tests to guide consumers' selection of skin care products | Interleukin is eligible to receive up to $2.3M in additional research funding in 2007 (3/30) |
| Notes: | |||
| * Private companies are indicated with an asterisk. N/A = Not available. | |||
| Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
| AMEX = American Stock Exchange. | |||
